1. Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission 
Kyoo-Hyung Lee, Je-Hwan Lee, Jung-Hee Lee, Dae-Young Kim, Han-Seung Park, Eun-Ji Choi, Sun-Hye Ko, Miee Seol, Young-Shin Lee, Young-A Kang, Mijin Jeon, Seunghyun Baek, You-Lee Kang, Sung-Han Kim, Sung-Cheol Yun, Hawk Kim, Jae-Cheol Jo, Yunsuk Choi, Young-Don Joo, Sung-Nam Lim 
Biology of Blood and Marrow Transplantation 
Volume 23, Issue 9, Pages (September 2017)
DOI: /j.bbmt
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Patient enrollment and subsequent donor assignment for allogeneic HCT. Three patients in the study received an alternate conditioning regimen for HCT and were, hence, excluded from the analysis as this was a major protocol violation. For HCT, patients assigned to UD or HFD received Bu2-Flu-ATG9.0 conditioning, while patients assigned to MSD received Bu4-Cy or Bu2-Flu-ATG4.5 conditioning (A). Yearly proportions of donor assignment during the study period are depicted (B). The pattern of donor assignment in the study changed with more HFD-HCT performed in the middle and later study period than in the initial period.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Leukemia recurrence, NRM, RFS, OS, and GVHD observed in the study. Cumulative incidences of leukemia recurrence (A), NRM (B), grades 2 to 4 acute GVHD (E), and moderate-to-severe chronic GVHD (F) according to the HCT donors are depicted. Kaplan-Meier plots of RFS (C) and OS (D) according to the HCT donors are also shown.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
CMV antigenemia and EBV DNA detection within 100 days after HCT. CMV pp65 antigenemia was assayed from the peripheral blood weekly. The cumulative incidences of its detection are depicted according to the HCT donor groups (A). EBV DNA was measured from the peripheral blood by quantitative PCR every 2 weeks. The cumulative incidences of detecting >1000 copies are depicted according to the HCT donor groups (B).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions